DOR is typically measured from the time a patient achieves a complete or partial response to the treatment until the time the disease progresses. Progression is usually determined through imaging studies, clinical evaluations, and other diagnostic tests. The precise methods for measuring DOR can vary depending on the type of cancer and the specific criteria set by clinical guidelines.
